Test stewardship, frequency and fidelity: Impact on reported hospital-onset Clostridioides difficile
暂无分享,去创建一个
Michael P Stevens | Gonzalo Bearman | Michele S Fleming | Olivia Hess | Heather L Albert | Emily Styslinger | Michelle Doll | Huong Jane Nguyen | Susan McAulay-Kidd | Robin R Hemphill | Tara Srivastava | Kaila D Cooper | G. Bearman | M. Stevens | M. Doll | K. Cooper | H. Nguyen | O. Hess | Robin R Hemphill | H. Albert | Emily Styslinger | S. McAulay-Kidd | T. Srivastava
[1] K. Carroll,et al. National Healthcare Safety Network laboratory‐identified Clostridium difficile event reporting: A need for diagnostic stewardship , 2018, American journal of infection control.
[2] A. Mathers,et al. Reduced Clostridium difficile Tests and Laboratory-Identified Events With a Computerized Clinical Decision Support Tool and Financial Incentive , 2018, Infection Control & Hospital Epidemiology.
[3] Daniel J. Morgan,et al. Diagnostic Stewardship—Leveraging the Laboratory to Improve Antimicrobial Use , 2017, JAMA.
[4] C. Burnham,et al. Diagnosis of Clostridium difficile Infection: Treat the Patient, Not the Test. , 2015, JAMA internal medicine.
[5] R. Weinstein,et al. Diagnostic Stewardship for Healthcare-Associated Infections: Opportunities and Challenges to Safely Reduce Test Use , 2018, Infection Control & Hospital Epidemiology.